About a third of people with depression don’t get better after two rounds of antidepressants. That number is cited often in research, but what it doesn’t capture is what that experience actually feels like from the inside.
It feels like running out of road.
You take the medication. You wait the weeks. You go back and say it didn’t really help, and then you start again with something else. At some point the question stops being “will this work?” and starts being “is anything going to?”
That’s what treatment-resistant depression looks like in real life. Not dramatic, not rare, just quiet and exhausting.
The clinical threshold is two adequate antidepressant trials without meaningful response. Around 30% of people with major depression meet that definition, according to a 2023 review published in the New England Journal of Medicine. Many of them simply keep trying variations of the same approach.
There are other options. Transcranial Magnetic Stimulation (TMS) is one of them, grounded in neuroscience, non-invasive, and increasingly part of how teams at The American Wellness Center in Dubai Healthcare City approach care when medication alone hasn’t been enough.
This isn’t about giving up on what you’ve tried. It’s about understanding why a different approach sometimes reaches places medication can’t.
What “Treatment-Resistant” Actually Means
The term sounds final. It isn’t.
Treatment-resistant depression is a clinical label, not a verdict. It means two or more antidepressant courses, taken at adequate doses for adequate time, haven’t produced a meaningful response. That’s the threshold. Nothing about it says untreatable.
What it actually says is that the approach hasn’t matched the biology yet.
Depression isn’t one thing. It presents differently across people, and the circuits involved vary too. Someone whose mood regulation is disrupted at a structural level in the brain may not respond the way someone with a primarily chemical imbalance does. Same diagnosis, different underlying picture.
The brain isn’t broken in these cases. It’s just not responding to what’s been tried.
That distinction matters, because the next step looks very different depending on whether you believe you’ve failed or whether you believe the treatment hasn’t been specific enough yet.
Why Medication Doesn’t Always Work
Most antidepressants work on neurotransmitters, adjusting serotonin, dopamine, or norepinephrine levels across the brain. For many people, that shift is enough to restore function and lift mood.
But not for everyone.
When depression involves reduced activity in specific regions, particularly the left prefrontal cortex, neurotransmitter adjustments may not reach the problem directly. The chemical environment changes, but the circuit stays quiet.
Research consistently puts the non-response rate to first-line antidepressants at around 40 to 60%. After a second failed trial, that number doesn’t shrink much. Each additional attempt draws from a smaller pool of options, and the side effect burden often grows.
That’s not a personal failure. It’s a pharmacological limitation.
Medication travels systemically. It affects the gut, sleep, weight, and libido alongside mood. For some people, managing those effects while waiting for a response that never quite arrives becomes its own source of exhaustion.
The question worth asking at that point isn’t “what else can I take?” It’s “is there a way to reach the part of the brain that isn’t responding?”
How TMS Works Differently
TMS, Transcranial Magnetic Stimulation, uses focused magnetic pulses to stimulate brain tissue directly. Nothing enters the body. There’s no sedation, no systemic effect, and no recovery time.
The pulses target the prefrontal cortex, the region most consistently underactive in people with depression that hasn’t responded to medication. When that area is stimulated repeatedly over a course of treatment, neurons begin to reconnect and resume more normal activity.
It’s local, where medication is systemic. That difference is exactly why it works for people who haven’t responded to drugs.
A few things worth knowing:
- Sessions are outpatient and last roughly 20 to 40 minutes
- Treatment typically runs daily over four to six weeks
- You remain fully awake and alert throughout
- Most people return to work or daily activity immediately after
Response rates for TMS for Depression in treatment-resistant cases range from 50 to 60% in clinical trials, with around a third achieving full remission. Those aren’t small numbers for people who’ve been told their options are running out.
TMS doesn’t replace what came before. It works alongside it, or steps in where it fell short.
Which raises a question most people eventually reach: who is this actually for, and what does the process of getting there look like?
TMS as a Next Step, Not a Last Resort
There’s a tendency to think of TMS as something you try when everything else has failed. That framing does it a disservice, and it delays care for people who could benefit sooner.
TMS is not a measure of desperation. It’s a measure of specificity.
When depression hasn’t responded to medication, it signals that the treatment needs to work at a different level. TMS is designed for exactly that point. Not after all hope is gone, but when the approach needs to become more targeted.
Candidates are typically people who have tried at least two antidepressants without adequate response, or those for whom medication side effects have become too disruptive to continue. Age, general health, and medical history all factor into suitability, assessed properly before anything begins.
One aspect that often surprises people is how well TMS pairs with therapy. When the prefrontal cortex is underactive, emotional processing is harder. Therapy asks a lot of a brain that’s struggling to regulate. TMS Combined with Psychotherapy works because stimulating those circuits first makes the brain more receptive. The therapeutic work lands differently when the neural environment has shifted.
It’s not about replacing one with the other. It’s about sequencing care in a way that gives both the best chance of working.
What to Realistically Expect
The first thing worth saying is that TMS is not fast-acting in the way people sometimes hope. The brain reorganises gradually, and that takes time.
Most people begin noticing something around the second or third week. Sleep often shifts first. Then the baseline mood starts to lift, not dramatically, but enough to notice.
Here’s what a standard course generally involves:
- Daily sessions, five days a week, for four to six weeks
- Each session lasting 20 to 40 minutes
- No anaesthesia, no downtime, no disruption to daily routine
- A tapping sensation on the scalp during stimulation, mild and temporary
- Mild headaches in the early sessions for some, which usually resolve quickly
Response isn’t guaranteed, and it doesn’t look the same for everyone. Roughly half of people with treatment-resistant depression see significant improvement. Around a third reach full remission. Some need a second course. Others find the gains are modest but meaningful.
It’s also worth noting that depression and anxiety frequently travel together. More than half of people with treatment-resistant depression carry a concurrent anxiety disorder. TMS for Anxiety Disorders follows similar principles, targeting overlapping neural circuits, which is why improvement in one condition often brings some relief in the other.
The honest summary is this: TMS won’t work for everyone, but for those it does reach, it often changes the trajectory of care in a way nothing else had managed to.
That’s worth a conversation.
When the Next Step Is a Different One
There’s a particular kind of tiredness that comes from trying to get better and not quite getting there. It isn’t weakness. It’s the weight of sustained effort without the return that was promised.
That experience is more common than most people realise, and more valid than most people allow themselves to feel.
Treatment-resistant depression doesn’t mean the door is closed. It means the door being tried isn’t the right one. That’s a meaningful difference, especially after months or years of waiting for something to shift.
TMS exists in that space. Not as a dramatic intervention, but as a quieter, more targeted form of care for a brain that hasn’t responded to what came before. The science behind it is solid. The process is manageable. And the decision to explore it doesn’t require certainty, only a willingness to ask a question.
Exhaustion is a reasonable place to be. It’s also a reasonable place to start from.
If the journey so far has felt like diminishing returns, speaking with a specialist isn’t giving up on what came before. It’s taking the next step with more information than before.
The TMS Therapy team at The American Wellness Center in Dubai Healthcare City works with people who are exactly at this point, not at the beginning of their mental health journey, but at a moment where care needs to become more specific.
That conversation doesn’t commit anyone to anything. It just opens something that’s been closed for long enough.
